• Profile
Close

Human leukocyte antigen-based risk stratification in heart transplant recipients—Implications for targeted surveillance

Journal of the American Heart Association Jul 30, 2019

Nilsson J, et al. - Researchers analyzed 34,681 recipients undergoing heart transplantation to assess the utility of human leukocyte antigen (HLA) mismatch in heart transplantation risk stratification to improve outcomes. The analysis revealed a greater risk of late graft loss in correlation to the HLA-DR/DQ allele/eplet mismatch. Further, eplet mismatch at the HLA-DRB1 and HLA-DQB1 loci on dis not impact graft survival more vs the allele mismatch at the same loci. Notably, they identified a significant relationship between the number of HLA allele/eplet mismatches and recipient age. Results thereby suggest the possibility for recognizing recipients with a heightened risk of future rejection and graft loss based on their HLA-DR/DQ allele/eplet mismatch load.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay